Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +15%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (495)

clinicaltrialsPublishedShowing 51–100 of 1,228 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06410248	Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma	recruiting	Phase 1	22	Northwestern UniversityOTHER	1	Sep 9, 2026	clinicaltrials
NCT06934889	Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma	recruiting	Phase 1	60	Memorial Sloan Kettering Cancer CenterOTHER	1	Sep 9, 2026	clinicaltrials